NASDAQ : RGNX
REGENXBIO Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 7.41 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 489.16M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
REGENXBIO Inc. (RGNX) reported revenue of 174.48M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Operating Revenue | 174.48M | 170.44M | 83.33M | 90.24M | 112.72M | 470.35M |
| Revenue | 174.48M | 170.44M | 83.33M | 90.24M | 112.72M | 470.35M |
| Cost of Revenue | 252.91M | 248.60M | 242.09M | 266.48M | 297.00M | 233.27M |
| Gross Profit | -78.42M | -78.16M | -158.76M | -176.24M | -184.27M | 237.08M |
| Selling, General & Admin | 85.56M | 82.86M | 76.62M | 87.79M | 85.28M | 79.33M |
| Other Operating Expenses | 167.00K | 179.00K | 865.00K | 397.00K | -14.18M | 333.00K |
| Operating Expenses | 85.72M | 83.04M | 72.48M | 88.19M | 71.10M | 77.10M |
| Operating Income | -164.15M | -161.20M | -231.25M | -264.43M | -255.38M | 159.98M |
| Interest Expense | -41.95M | -45.01M | -12.66M | -6.86M | -23.25M | -26.28M |
| Interest & Investment Income | 9.66M | 12.33M | 18.90M | 11.34M | 5.72M | 7.54M |
| EBT Excluding Unusual Items | -196.43M | -193.88M | -225.00M | -259.95M | -272.90M | 141.25M |
| Merger & Restructuring Charges | -3.70M | |||||
| Asset Writedown | -2.10M | |||||
| Other Unusual Items | -7.50M | |||||
| Pretax Income | -196.43M | -193.88M | -227.10M | -263.65M | -280.40M | 141.25M |
| Income Tax Expense | -152.00K | -84.00K | 13.41M | |||
| Net Income | -196.43M | -193.88M | -227.10M | -263.49M | -280.32M | 127.84M |
| Net Income to Common | -196.43M | -193.88M | -227.10M | -263.49M | -280.32M | 127.84M |
| Shares Outstanding (Basic) | 52.17M | 51.57M | 49.51M | 43.73M | 43.15M | 42.44M |
| Shares Outstanding (Diluted) | 52.17M | 51.57M | 49.51M | 43.73M | 43.15M | 43.91M |
| EPS (Basic) | -3.76 | -3.76 | -4.59 | -6.02 | -6.50 | 3.01 |
| EPS (Diluted) | -3.77 | -3.76 | -4.59 | -6.02 | -6.50 | 2.91 |
| Free Cash Flow | -249.67M | -126.38M | -175.56M | -228.37M | -238.21M | 134.70M |
| Free Cash Flow Per Share | -4.79 | -2.45 | -3.55 | -5.22 | -5.52 | 3.07 |
| Gross Margin | -44.95% | -45.86% | -190.53% | -195.29% | -163.47% | 50.41% |
| Operating Margin | -94.08% | -94.58% | -277.51% | -293.02% | -226.55% | 34.01% |
| Profit Margin | -112.58% | -113.75% | -272.54% | -291.99% | -248.68% | 27.18% |
| Free Cash Flow Margin | -143.09% | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% |
| EBITDA | -148.78M | -145.58M | -215.03M | -247.11M | -242.47M | 169.54M |
| EBITDA Margin | -85.27% | -85.41% | -258.05% | -273.83% | -215.10% | 36.05% |
| D&A For EBITDA | 15.37M | 15.62M | 16.21M | 17.32M | 12.91M | 9.56M |
| EBIT | -164.15M | -161.20M | -231.25M | -264.43M | -255.38M | 159.98M |
| EBIT Margin | -94.08% | -94.58% | -277.51% | -293.02% | -226.55% | 34.01% |
| Effective Tax Rate | 9.49% | |||||
| Revenue as Reported | 174.48M | 170.44M | 83.33M | 90.24M | 112.72M | 470.35M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 36.49M | 34.47M | 57.53M | 34.52M | 96.95M | 345.21M |
| Short-Term Investments | 69.03M | 195.60M | 177.16M | 240.74M | 267.69M | 112.23M |
| Cash & Short-Term Investments | 105.52M | 230.07M | 234.69M | 275.26M | 364.64M | 457.44M |
| Accounts Receivable | 106.75M | 26.38M | 20.47M | 24.79M | 28.08M | 28.51M |
| Other Receivables | 10.88M | 11.88M | 12.40M | 19.30M | 8.50M | |
| Receivables | 117.64M | 38.25M | 32.87M | 44.09M | 36.59M | 28.51M |
| Prepaid Expenses | 11.90M | 11.93M | 9.07M | 14.52M | 13.90M | 18.75M |
| Other Current Assets | 873.00K | 1.03M | 1.38M | 1.11M | 848.00K | 14.12M |
| Total Current Assets | 236.16M | 281.28M | 278.00M | 334.97M | 415.98M | 518.83M |
| Property, Plant & Equipment | 142.32M | 152.01M | 171.31M | 192.59M | 206.80M | 192.45M |
| Long-Term Investments | 10.79M | 10.18M | 38.87M | 200.56M | 391.91M | |
| Long-Term Accounts Receivable | 435.00K | 2.31M | 474.00K | 701.00K | 1.50M | 2.26M |
| Other Long-Term Assets | 7.71M | 6.64M | 6.03M | 6.84M | 8.43M | 8.46M |
| Total Assets | 386.62M | 453.03M | 465.99M | 573.97M | 833.27M | 1.11B |
| Accounts Payable | 15.55M | 21.36M | 22.80M | 22.79M | 27.21M | 11.39M |
| Accrued Expenses | 23.03M | 38.36M | 37.91M | 49.32M | 45.99M | 59.50M |
| Current Portion of Long-Term Debt | 26.77M | 39.61M | 34.31M | 50.57M | 48.60M | 37.89M |
| Current Portion of Leases | 7.36M | 8.29M | 7.90M | 7.07M | 6.00M | 1.75M |
| Current Income Taxes Payable | 11.32M | |||||
| Current Unearned Revenue | 9.88M | 10.45M | 115.00K | 148.00K | 1.83M | 3.33M |
| Other Current Liabilities | 46.00K | 33.00K | 156.00K | 386.00K | 806.00K | 5.29M |
| Total Current Liabilities | 82.62M | 118.09M | 103.19M | 130.27M | 130.43M | 130.47M |
| Long-Term Debt | 154.75M | 147.41M | 25.38M | 43.48M | 89.00M | 133.46M |
| Long-Term Leases | 61.60M | 65.22M | 74.13M | 82.22M | 88.80M | 84.93M |
| Long-Term Unearned Revenue | 15.40M | 18.94M | ||||
| Other Long-Term Liabilities | 486.00K | 638.00K | 3.63M | 6.25M | 8.83M | 745.00K |
| Total Liabilities | 314.85M | 350.30M | 206.34M | 262.23M | 317.07M | 349.61M |
| Common Stock | 5.00K | 5.00K | 5.00K | 4.00K | 4.00K | 4.00K |
| Additional Paid-In Capital | 1.27B | 1.23B | 1.19B | 1.02B | 973.14M | 928.10M |
| Retained Earnings | -1.19B | -1.13B | -932.15M | -705.05M | -441.55M | -161.23M |
| Comprehensive Income & Other | -875.00K | -687.00K | -741.00K | -4.43M | -15.40M | -2.57M |
| Shareholders' Equity | 71.77M | 102.73M | 259.65M | 311.74M | 516.20M | 764.30M |
| Total Liabilities & Equity | 386.62M | 453.03M | 465.99M | 573.97M | 833.27M | 1.11B |
| Total Debt | 250.46M | 260.52M | 141.72M | 183.34M | 232.41M | 258.03M |
| Net Cash (Debt) | -144.94M | -19.66M | 103.15M | 130.79M | 332.80M | 591.32M |
| Net Cash Per Share | -2.78 | -0.38 | 2.08 | 2.99 | 7.71 | 13.47 |
| Filing Date Shares Outstanding | 66.01M | 51.61M | 50.09M | 44.43M | 43.46M | 42.95M |
| Total Common Shares Outstanding | 54.16M | 50.89M | 49.55M | 44.05M | 43.30M | 42.83M |
| Working Capital | 153.54M | 163.19M | 174.81M | 204.70M | 285.54M | 388.35M |
| Book Value Per Share | 1.32 | 2.02 | 5.24 | 7.08 | 11.92 | 17.84 |
| Tangible Book Value | 71.77M | 102.73M | 259.65M | 311.74M | 516.20M | 764.30M |
| Tangible Book Value Per Share | 1.32 | 2.02 | 5.24 | 7.08 | 11.92 | 17.84 |
| Machinery | 90.64M | 90.44M | 88.42M | 87.38M | 83.68M | 68.05M |
| Leasehold Improvements | 101.74M | 101.61M | 101.47M | 101.93M | 99.40M | 92.53M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -196.43M | -193.88M | -227.10M | -263.49M | -280.32M | 127.84M |
| Depreciation & Amortization | 15.37M | 15.62M | 16.21M | 17.32M | 12.91M | 9.56M |
| Asset Writedown & Restructuring Costs | 2.10M | |||||
| Loss (Gain) From Sale of Investments | -4.45M | -5.54M | -10.76M | -1.52M | 4.79M | 653.00K |
| Stock-Based Compensation | 35.04M | 34.56M | 38.46M | 40.27M | 40.79M | 38.81M |
| Provision & Write-off of Bad Debts | -5.00M | -2.57M | ||||
| Other Operating Activities | 20.75M | 13.50M | 7.42M | -95.00K | 368.00K | 4.36M |
| Change in Accounts Receivable | -85.34M | -7.66M | 9.71M | 3.94M | 4.82M | 14.12M |
| Change in Accounts Payable | -6.11M | -2.28M | -292.00K | -2.79M | 18.79M | -2.30M |
| Change in Unearned Revenue | -12.49M | 29.28M | -33.00K | -1.51M | -1.17M | -899.00K |
| Change in Other Net Operating Assets | -13.02M | -7.55M | -3.85M | -10.52M | -8.47M | 29.30M |
| Operating Cash Flow | -246.67M | -123.96M | -173.12M | -218.41M | -207.49M | 218.88M |
| Capital Expenditures | -2.99M | -2.41M | -2.44M | -9.96M | -30.72M | -84.17M |
| Investment in Securities | 219.33M | -13.45M | 105.88M | 200.90M | 18.80M | -322.47M |
| Investing Cash Flow | 216.34M | -15.87M | 103.45M | 190.94M | -11.93M | -406.64M |
| Issuance of Common Stock | 21.18M | 1.37M | 133.77M | 8.22M | 4.55M | 222.49M |
| Repurchase of Common Stock | -951.00K | -633.00K | -910.00K | -419.00K | -284.00K | -2.00K |
| Other Financing Activities | -32.96M | 116.04M | -40.18M | -42.77M | -33.10M | -27.23M |
| Financing Cash Flow | -12.73M | 116.77M | 92.68M | -34.97M | -28.84M | 195.25M |
| Net Cash Flow | -43.07M | -23.06M | 23.00M | -62.43M | -248.26M | 7.48M |
| Free Cash Flow | -249.67M | -126.38M | -175.56M | -228.37M | -238.21M | 134.70M |
| Free Cash Flow Margin | -143.09% | -74.15% | -210.69% | -253.06% | -211.32% | 28.64% |
| Free Cash Flow Per Share | -4.79 | -2.45 | -3.55 | -5.22 | -5.52 | 3.07 |
| Levered Free Cash Flow | -184.26M | -79.79M | -95.45M | -133.51M | -156.11M | 72.51M |
| Unlevered Free Cash Flow | -158.05M | -51.66M | -87.54M | -129.22M | -141.58M | 88.93M |
| Cash Interest Paid | 32.11M | 32.11M | 6.56M | 7.28M | 23.12M | 21.64M |
| Cash Income Tax Paid | 285.00K | 285.00K | -72.00K | -142.00K | 11.81M | 6.00M |
| Change in Working Capital | -116.95M | 11.78M | 5.53M | -10.89M | 13.98M | 40.22M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 481.90M | 728.97M | 382.98M | 789.66M | 981.90M | 1.40B |
| Enterprise Value | 626.84M | 695.07M | 250.23M | 621.67M | 600.62M | 1.13B |
| Last Close Price | 7.20 | 14.40 | 7.73 | 17.95 | 22.68 | 32.70 |
| PE Ratio | 10.94 | |||||
| Forward PE | 35.95 | 54.68 | 54.68 | 54.68 | 76.17 | |
| PS Ratio | 2.72 | 4.28 | 4.60 | 8.75 | 8.71 | 2.97 |
| PB Ratio | 5.43 | 7.10 | 1.48 | 2.53 | 1.90 | 1.83 |
| P/TBV Ratio | 6.62 | 7.10 | 1.48 | 2.53 | 1.90 | 1.83 |
| P/FCF Ratio | 10.38 | |||||
| P/OCF Ratio | 6.39 | |||||
| EV/Sales Ratio | 3.55 | 4.08 | 3.00 | 6.89 | 5.33 | 2.40 |
| EV/EBITDA Ratio | 6.67 | |||||
| EV/EBIT Ratio | 7.06 | |||||
| EV/FCF Ratio | 8.39 | |||||
| Debt / Equity Ratio | 3.49 | 2.54 | 0.55 | 0.59 | 0.45 | 0.34 |
| Debt / EBITDA Ratio | 1.42 | |||||
| Debt / FCF Ratio | 1.92 | |||||
| Net Debt / Equity Ratio | 2.02 | 0.19 | -0.40 | -0.42 | -0.65 | -0.77 |
| Net Debt / EBITDA Ratio | -0.97 | -0.14 | 0.48 | 0.53 | 1.37 | -3.49 |
| Net Debt / FCF Ratio | -0.58 | -0.16 | 0.59 | 0.57 | 1.40 | -4.39 |
| Asset Turnover | 0.36 | 0.37 | 0.16 | 0.13 | 0.12 | 0.52 |
| Quick Ratio | 2.70 | 2.27 | 2.59 | 2.45 | 3.08 | 3.73 |
| Current Ratio | 2.86 | 2.38 | 2.69 | 2.57 | 3.19 | 3.98 |
| Return on Equity (ROE) | -137.63% | -107.00% | -79.49% | -63.65% | -43.78% | 22.39% |
| Return on Assets (ROA) | -21.20% | -21.93% | -27.79% | -23.49% | -16.39% | 10.97% |
| Return on Invested Capital (ROIC) | -97.79% | -107.51% | -119.66% | -87.59% | -53.83% | 39.52% |
| Return on Capital Employed (ROCE) | -54.00% | -48.10% | -63.70% | -59.60% | -36.30% | 16.30% |
| Earnings Yield | -51.58% | -26.60% | -59.30% | -33.37% | -28.55% | 9.14% |
| FCF Yield | -52.53% | -17.34% | -45.84% | -28.92% | -24.26% | 9.63% |
| Buyback Yield / Dilution | -2.03% | -4.17% | -13.21% | -1.35% | 1.73% | -17.79% |